Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270891 · ClinicalTrials.gov registry record · NA
Pharmacogenomic Testing in Primary Care
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT03270891 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 75 participants.
The verdict
NCT03270891, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a 6-month randomized, wait-listed, controlled pilot trial conducted in 6 department of family medicine (DFM) clinics at the University of Michigan (UM). Physicians practicing at a UM DFM clinical site who are willing to utilize pharmacogenomic (PGx) test results to manage antidepressant use will be enrolled. Patients of these DFM physicians who are adults with a new prescription for a target antidepressant will also be enrolled.
Interventions
- DIAGNOSTIC_TEST PGx test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2022-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03270891
The ClinicalTrials.gov registry entry for NCT03270891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PGx test is the first listed.
NCT03270891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03270891 about?
NCT03270891 is a clinical study titled "Pharmacogenomic Testing in Primary Care". This is a 6-month randomized, wait-listed, controlled pilot trial conducted in 6 department of family medicine (DFM) clinics at the University of Michigan (UM). Physicians practicing at a UM DFM clinical site who are willing to utilize pharmacogenomic (PGx) test results to manage antidepressant use ...
What is the current status of trial NCT03270891?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-12-01. Estimated completion is 2022-05-06.
What interventions are being tested in trial NCT03270891?
The interventions under investigation include: PGx test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03270891?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.